Blockade of CD93 with monoclonal antibodies against CD93 (anti-CD93) markedly inhibited lung tumor growth by inducing CCL21 secretion from pMCs and preventing tumor angiogenesis, thus showing better efficacy than blocking vascular endothelial growth factor receptor (VEGFR). The gene discussed is KDR; the disease is neoplasm.